ArriVent BioPharma in Newtown Square is working on a deal potentially worth more than $1 billion to acquire the rights for an ...

Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

Mab’s pipeline pivot had a sting in the tail. Weeks after shifting its focus, the biotech said Wednesday that it has reduced ...

In this webinar, expert panelists discuss the key challenges in complex mAb purification and offer practical solutions to optimize downstream processing systems for even the most complex mAb formats.< ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Biopharma start-up Helicore Biopharma has emerged from stealth with $65 million from a series A round co-led by Versant ...

ProMIS Neurosciences Inc., a clinical-stage biopharmaceutical company, made significant disclosures in its recent 8-K filing with the Securities and Exchange Commission. In its filing dated January 27 ...

SEC asks SII to submit more data for approval of recombinant mAB for dengue treatment in adults: Our Bureau, New Delhi Wednesday, January 29, 2025, 08:00 Hrs [IST] The Subject Exp ...

Avalo Therapeutics, Inc.’s AVTX share price has surged by 12.29%, which has investors questioning if this is right time to ...

The soaring demand for antidiabetic and weight-loss drugs has lured in many biotech and big Pharma companies. Onto this ...

The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...